Industry Overview:
The global pet biotics market is estimated to reach USD 875.4 million in 2025, reflecting a Y-O-Y of 7.1%. Growth driven by high preferences to adapt gut- and immune strong focused pet supplements due to rapid adoption of veterinary to promote biotics and clinically validated probiotic and synbiotic formulations. Increasing investments in functional pet nutrition research with expansion of digital sales channels are leading higher product penetration across dogs, cats, and specialty pets. In an advanced delivery systems including microencapsulation and shelf-stable blends are improving efficacy with reducing degradation and extending demand across preventive care, therapeutic use, and daily nutrition segments among others.
Industry Insights: Scale, Segments, and Shifts
• Market Size & Growth: The global pet biotics market is projected to reach USD 1,722.0 million by 2035 with registering a CAGR of 7.0% between 2025 and 2035.
• Segment Analysis: Probiotics segment capture approximately 56% of the share owing to their strong requirement for wellness support in pets, while prebiotics it is expected to showing the fastest growth during the forecast period due to consumer high demand for clean-label or plant-based ingredients are supporting to long-term health and vitality.
• Regional Highlights: Expanding pet ownership and rapid adoption of e-commerce channels due to Asia Pacific holds nearly 45% of the market share in 2024. North America gaining momentum for premiumization trends and growing veterinary recommendations.
• Competitive Landscape: The market is moderately consolidated with competitors like Alltech, Kerry Group plc, and Probi. These players are focusing to support or invest for innovative strain formulations which also support to advanced delivery systems and enhancing strategic veterinary partnerships to strengthen market presence.
Factors Shaping the Next Decade
• Market Gaps / Restraints: It is showing more complexity in manufacturing to ensuring the viability of live probiotic strains or heat and moisture sensitivity in distribution logistics and limited awareness of consumer about prebiotics and postbiotics.
• Key Trends and Innovations: The industry is witnessing a transforming towards adapt strain-specific probiotic and synbiotic formulations with also microencapsulation and shelf-stable delivery systems. The rapid deployment of postbiotic enriched supplements or enzyme- are enhanced microbiome solutions and functional prebiotic technologies is improving product stability or effectiveness and adoption across chews, treats and dry food formats.
• Potential Opportunities: Adaption of strain especially customized postbiotic blends or creation of time to release and functional gel delivery systems and adoption of integrated microbiome monitoring with personalized nutrition plans are expected to generate new revenue streams.
Recent Industry Updates:
• May 2025: Kemin Industries enhancing its innovation footprint across the pet health and nutrition space by acquiring Bactana® it is a fermentation and intestinal microbiota research company which helps to accelerating development of gut‑focused ingredient solutions for companion animal nutrition.
• April 2025: International Flavors & Fragrances Inc. company has expanded its pet nutrition portfolio with advanced enzyme‑based and functional solutions both are beneficial to enhance microbiome support in hydration and odour control for pets including novel microbiome for products and hydration are supporting ingredients for dogs and cats.
• January 2025: BENEO GmbH has launched BeneoCarb S which is a low‑glycaemic syrup for pet food applications that offers a natural alternative to traditional glucose syrup and caramel to supporting balanced blood glucose management with improved palatability. The product stability in semi‑moist and moist foods addressing rising pet obesity and health‑focused nutrition trends.
Industry Outlook Scope:
By Type
• Probiotics
• Prebiotics
• Postbiotics
By Form
• Powders
• Capsules/Tablets
• Liquids
• Chews & Treats
By Pet
• Dogs
• Cats
• Others
By Function
• Digestive/ Gut Health
• Immune Modulation
• Metabolic & Weight Management
• Oral & Dental Health
• Others
By Application
• Preventive Care
• Therapeutic / Clinical Use
• Daily Nutrition & Wellness
Geographical Insights: Emerging Corridors of Growth
• Regional Overview: In Europe fastest growing economy contribute to largest share only for required to follow veterinary safety standards and incentives for gut-health research. In a Middle East & Africa is witnessing increasing demand due to urban luxury pet lifestyle trends and rapid growth of veterinary specialty clinics to supporting premium pet biotics sales. In South America expected to gaining momentum only for linked to localized probiotic manufacturing hubs and collaboration with academic research institutions has enables to development of region-specific formulations for local pets.
Download the free regional report sample.
• Countries to Watch: Brazil is lead to growth due to growing veterinary nutrition programs and high urban pet ownership. UAE stands out with luxury pet care consumption and specialized wellness clinics, while France drives innovation adoption through many states in these countries are supported to microbiome studies and premium pet food R&D.
Regulatory Environment and Policy Support
• Government Regulations & Supportive Policies: Global pet biotics manufacturers are aligned with the U.S. FDA Center for Veterinary Medicine (CVM) regulations under the Federal Food, Drug, and Cosmetic Act (FD&C Act) or European Union Feed Additives Regulation (EC) No 1831/2003. They are ensuring to required product safety which also support for labelling compliance and standardized evaluation of probiotic and prebiotic ingredients. These frameworks promote to adoption by building trust to ensuring regulatory compliance and enabling cross-border trade of functional pet nutrition products.
• Key Government Initiatives: Initiatives like the European Partnership on Animal Health and Welfare under Horizon Europe has approved almost €600 million and the USDA/NIFA Animal Health & Nutrition Research Grants. Above all are encouraged to innovation or clinical validation and research in microbiome-based pet nutrition are supporting to new product development.
Competitive Landscape and Strategic Outlook
The Pet biotics industry is moderately concentrated, with competitors expanding their services and product offerings and developing strategic R&D partnerships in order to dominate. Major businesses have given importance to digital veterinarian interaction platforms and clinically confirmed formulations with breed- and age-specific solutions. In order to gain market momentum, innovators have introduced subscription-based nutrition plans as well as personalized microbiome solutions, while emerging regional manufacturers face off through cost-optimized production and niche distribution.
Industry Competition:
• ADM
• Alltech
• Kerry Group plc
• International Flavors & Fragrances Inc.
• Dsm-firmenich
• Probi
• Kemin Industries, Inc.
• BENEO GmbH
• Ingredion
• Lallemand Inc
• Sacco System
• Orffa
Analyst Perspective
The pet biotics industry is moving towards rapid expansion driven by functional wellness trends and microbiome focused innovation. In upcoming next three to five years, the personalized nutrition with clinically validated probiotic strains and digital pet health monitoring will be expected to drive. In small and mid-sized companies are ready to investing to formulations or veterinary collaborations and targeted consumer education are expected to achieve superior market penetration and long-term brand loyalty in this evolving sector.
What to Expect from Outlook:
1. Save time carrying out entry-level research by identifying the size, growth trends, major segments, and leading companies in the global pet biotics market.
2. Use PORTER’s Five Forces analysis to assess the competitive intensity and overall attractiveness of the global pet biotics market sector.
3. Profiles of leading companies provide insights into key players’ regional operations, strategies, financial results, and recent initiatives.
4. Add weight to presentations and pitches by understanding the future growth prospects of the global pet biotics market with a forecast for the decade by both market share (%) & revenue (USD Million).
1. Introduction
1.1. Executive Summary
1.2. Regional Snapshot
1.3. Market Scope
1.4. Market Definition
2. Across
The Globe
2.1. Factors Affecting End Use Industries
2.2. Market Dynamics
2.2.1. Upcoming Opportunities
2.2.2. Ongoing Market Trends
2.2.3. Growth Driving Factors
2.2.4. Restraining Factors
2.3. Value Chain Analysis
2.3.1. List of Manufacturers
2.3.2. List of Distributors/Suppliers
2.3.3. List of End Users
2.4. PORTER’s & PESTLE Analysis
2.5. Key Developments
2.6. Key Regulations & Certifications
3. Global
Pet Biotics Market Overview, By Type
3.1. Market Size (US$ Mn) Analysis, 2020 –
2035
3.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
3.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
3.3.1. Probiotics
3.3.2. Prebiotics
3.3.3. Postbiotics
4. Global
Pet Biotics Market Overview, By Form
4.1. Market Size (US$ Mn) Analysis, 2020 –
2035
4.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
4.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
4.3.1. Powders
4.3.2. Capsules/Tablets
4.3.3. Liquids
4.3.4. Chews & Treats
5. Global
Pet Biotics Market Overview, By Pet
5.1. Market Size (US$ Mn) Analysis, 2020 –
2035
5.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
5.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
5.3.1. Dogs
5.3.2. Cats
5.3.3. Others
6. Global
Pet Biotics Market Overview, By Function
6.1. Market Size (US$ Mn) Analysis, 2020 –
2035
6.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
6.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
6.3.1. Digestive/ Gut Health
6.3.2. Immune Modulation
6.3.3. Metabolic & Weight Management
6.3.4. Oral & Dental Health
6.3.5. Others
7. Global
Pet Biotics Market Overview, By Application
7.1. Market Size (US$ Mn) Analysis, 2020 –
2035
7.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
7.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
7.3.1. Preventive Care
7.3.2. Therapeutic / Clinical Use
7.3.3. Daily Nutrition & Wellness
8. Global
Pet Biotics Market Overview, By Region
8.1. Market Size (US$ Mn) Analysis, 2020 –
2035
8.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
8.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Middle East & Africa
8.3.5. South America
9. North
America Pet Biotics Market Overview
9.1. Market Size (US$ Mn) Analysis, 2020 –
2035
9.2. Market Share (%) Analysis (2024 vs
2035), Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness
Analysis (2025 - 2035)
9.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
9.3.1. By Country
9.3.1.1. U.S.
9.3.1.2. Canada
9.3.1.3. Mexico
9.3.2. By Type
9.3.3. By Form
9.3.4. By Pet
9.3.5. By Function
9.3.6. By Application
10. Europe Pet
Biotics Market Overview
10.1. Market Size (US$ Mn) Analysis, 2020 – 2035
10.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
10.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
10.3.1. By Country
10.3.1.1. UK
10.3.1.2. Italy
10.3.1.3. Spain
10.3.1.4. Germany
10.3.1.5. France
10.3.1.6. BENELUX
10.3.1.7. Nordics
10.3.1.8. Rest of Europe
10.3.2. By Type
10.3.3. By Form
10.3.4. By Pet
10.3.5. By Function
10.3.6. By Application
11. Asia
Pacific Pet Biotics Market Overview
11.1. Market Size (US$ Mn) Analysis, 2020 – 2035
11.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
11.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
11.3.1. By Country
11.3.1.1. China
11.3.1.2. Japan
11.3.1.3. India
11.3.1.4. South Korea
11.3.1.5. ASEAN
11.3.1.6. Australia & New Zealand
11.3.1.7. Rest of Asia Pacific
11.3.2. By Type
11.3.3. By Form
11.3.4. By Pet
11.3.5. By
Function
11.3.6. By
Application
12. Middle East
& Africa Pet Biotics Market Overview
12.1. Market Size (US$ Mn) Analysis, 2020 – 2035
12.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
12.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
12.3.1. By Country
12.3.1.1. GCC
12.3.1.2. South Africa
12.3.1.3. Rest of Middle East & Africa
12.3.2. By Type
12.3.3. By Form
12.3.4. By Pet
12.3.5. By Function
12.3.6. By Application
13. South
America Pet Biotics Market Overview
13.1. Market Size (US$ Mn) Analysis, 2020 – 2035
13.2. Market Share (%) Analysis (2024 vs 2035),
Y-o-Y Growth (%) Analysis (2025 - 2035) & Market Attractiveness Analysis
(2025 - 2035)
13.3. Market Absolute $ Opportunity Analysis,
2020 – 2035
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Chile
13.3.1.3. Rest of South America
13.3.2. By Type
13.3.3. By Form
13.3.4. By Pet
13.3.5. By Function
13.3.6. By Application
14. Country-Wise
Market Analysis
14.1. Growth Comparison by Key Countries
15. Competitive
Landscape
15.1. Market Share (%) Analysis, By Top Players
15.2. Market Structure Analysis, By Tier I &
II Companies
16. Company
Profiles
16.1. ADM
16.1.1. Company Overview
16.1.2. Business Segments
16.1.3. Financial Insights
16.1.4. Key Business Aspects (Noise Analysis)
16.2. Alltech
16.3. Kerry Group plc
16.4. International Flavors & Fragrances Inc.
16.5. Dsm-firmenich
16.6. Probi
16.7. Kemin Industries, Inc.
16.8. BENEO GmbH
16.9. Ingredion
16.10. Lallemand Inc
16.11. Sacco System
16.12. Orffa
17. Analysis
& Recommendations
17.1. Targeting Segment
17.2. Targeting Region
17.3. Market Approach
18. Research
Methodology
19. Disclaimer
